vs
Reservoir Media, Inc.（RSVR）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
Reservoir Media, Inc.的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.3倍（$45.6M vs $35.5M），Reservoir Media, Inc.净利率更高（4.8% vs -304.2%，领先309.1%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 7.7%），Reservoir Media, Inc.自由现金流更多（$12.8M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 7.9%）
Reservoir Media是全球领先的独立音乐版权管理企业，拥有并管理海量录音、音乐出版及邻接权版权库，合作各流派知名词曲作者、歌手与制作人，为流媒体平台、影视制作、广告、现场演出等场景提供版权授权服务，业务覆盖北美、欧洲、亚太等主要市场。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
RSVR vs RXRX — 直观对比
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $45.6M | $35.5M |
| 净利润 | $2.2M | $-108.1M |
| 毛利率 | 64.5% | 59.8% |
| 营业利润率 | 22.7% | -304.8% |
| 净利率 | 4.8% | -304.2% |
| 营收同比 | 7.7% | 681.7% |
| 净利润同比 | -58.1% | 39.6% |
| 每股收益（稀释后） | $0.03 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $45.6M | $35.5M | ||
| Q3 25 | $45.4M | $5.2M | ||
| Q2 25 | $37.2M | $19.2M | ||
| Q1 25 | $41.4M | $14.7M | ||
| Q4 24 | $42.3M | $4.5M | ||
| Q3 24 | $40.7M | $26.1M | ||
| Q2 24 | $34.3M | $14.4M | ||
| Q1 24 | $39.1M | $13.8M |
| Q4 25 | $2.2M | $-108.1M | ||
| Q3 25 | $2.3M | $-162.3M | ||
| Q2 25 | $-555.7K | $-171.9M | ||
| Q1 25 | $2.7M | $-202.5M | ||
| Q4 24 | $5.2M | $-178.9M | ||
| Q3 24 | $185.0K | $-95.8M | ||
| Q2 24 | $-346.7K | $-97.5M | ||
| Q1 24 | $2.8M | $-91.4M |
| Q4 25 | 64.5% | 59.8% | ||
| Q3 25 | 63.6% | -183.8% | ||
| Q2 25 | 64.5% | -4.9% | ||
| Q1 25 | 65.6% | -48.0% | ||
| Q4 24 | 64.4% | -181.4% | ||
| Q3 24 | 63.5% | 53.7% | ||
| Q2 24 | 61.3% | 36.2% | ||
| Q1 24 | 63.4% | 19.1% |
| Q4 25 | 22.7% | -304.8% | ||
| Q3 25 | 23.5% | -3327.6% | ||
| Q2 25 | 14.7% | -916.8% | ||
| Q1 25 | 25.2% | -1297.9% | ||
| Q4 24 | 22.6% | -4042.4% | ||
| Q3 24 | 24.9% | -377.1% | ||
| Q2 24 | 14.5% | -697.4% | ||
| Q1 24 | 22.4% | -698.4% |
| Q4 25 | 4.8% | -304.2% | ||
| Q3 25 | 5.0% | -3135.3% | ||
| Q2 25 | -1.5% | -894.2% | ||
| Q1 25 | 6.4% | -1373.3% | ||
| Q4 24 | 12.4% | -3935.5% | ||
| Q3 24 | 0.5% | -367.5% | ||
| Q2 24 | -1.0% | -676.6% | ||
| Q1 24 | 7.1% | -662.4% |
| Q4 25 | $0.03 | $-0.17 | ||
| Q3 25 | $0.03 | $-0.36 | ||
| Q2 25 | $-0.01 | $-0.41 | ||
| Q1 25 | — | $-0.50 | ||
| Q4 24 | $0.08 | $-0.56 | ||
| Q3 24 | — | $-0.34 | ||
| Q2 24 | $-0.01 | $-0.40 | ||
| Q1 24 | — | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $20.6M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $373.6M | $1.1B |
| 总资产 | $941.9M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | $20.6M | $743.3M | ||
| Q3 25 | $27.9M | $659.8M | ||
| Q2 25 | $14.9M | $525.1M | ||
| Q1 25 | $21.4M | $500.5M | ||
| Q4 24 | $17.8M | $594.4M | ||
| Q3 24 | $21.1M | $427.6M | ||
| Q2 24 | $16.4M | $474.3M | ||
| Q1 24 | $18.1M | $296.3M |
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
| Q4 25 | $373.6M | $1.1B | ||
| Q3 25 | $370.9M | $1.0B | ||
| Q2 25 | $368.9M | $919.1M | ||
| Q1 25 | $364.9M | $933.9M | ||
| Q4 24 | $359.5M | $1.0B | ||
| Q3 24 | $357.9M | $524.6M | ||
| Q2 24 | $353.0M | $584.4M | ||
| Q1 24 | $353.0M | $401.2M |
| Q4 25 | $941.9M | $1.5B | ||
| Q3 25 | $903.5M | $1.4B | ||
| Q2 25 | $857.0M | $1.3B | ||
| Q1 25 | $865.1M | $1.3B | ||
| Q4 24 | $832.4M | $1.4B | ||
| Q3 24 | $778.2M | $726.5M | ||
| Q2 24 | $768.2M | $775.9M | ||
| Q1 24 | $783.5M | $557.8M |
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $12.9M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $12.8M | $-47.3M |
| 自由现金流率自由现金流/营收 | 28.1% | -133.1% |
| 资本支出强度资本支出/营收 | 0.3% | 3.5% |
| 现金转化率经营现金流/净利润 | 5.89× | — |
| 过去12个月自由现金流最近4个季度 | $50.1M | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $12.9M | $-46.1M | ||
| Q3 25 | $19.3M | $-117.4M | ||
| Q2 25 | $6.0M | $-76.4M | ||
| Q1 25 | $12.2M | $-132.0M | ||
| Q4 24 | $11.2M | $-115.4M | ||
| Q3 24 | $13.3M | $-59.2M | ||
| Q2 24 | $8.6M | $-82.2M | ||
| Q1 24 | $13.8M | $-102.3M |
| Q4 25 | $12.8M | $-47.3M | ||
| Q3 25 | $19.2M | $-117.6M | ||
| Q2 25 | $6.0M | $-79.6M | ||
| Q1 25 | $12.2M | $-133.8M | ||
| Q4 24 | $11.2M | $-116.7M | ||
| Q3 24 | $13.3M | $-63.8M | ||
| Q2 24 | $8.5M | $-83.4M | ||
| Q1 24 | $13.8M | $-109.0M |
| Q4 25 | 28.1% | -133.1% | ||
| Q3 25 | 42.2% | -2272.5% | ||
| Q2 25 | 16.1% | -413.9% | ||
| Q1 25 | 29.3% | -907.4% | ||
| Q4 24 | 26.5% | -2567.7% | ||
| Q3 24 | 32.7% | -244.6% | ||
| Q2 24 | 24.9% | -578.5% | ||
| Q1 24 | 35.2% | -789.9% |
| Q4 25 | 0.3% | 3.5% | ||
| Q3 25 | 0.3% | 4.7% | ||
| Q2 25 | 0.1% | 16.4% | ||
| Q1 25 | 0.1% | 12.4% | ||
| Q4 24 | 0.0% | 28.6% | ||
| Q3 24 | 0.1% | 17.5% | ||
| Q2 24 | 0.1% | 8.2% | ||
| Q1 24 | 0.0% | 48.2% |
| Q4 25 | 5.89× | — | ||
| Q3 25 | 8.54× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 4.56× | — | ||
| Q4 24 | 2.14× | — | ||
| Q3 24 | 71.97× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 4.93× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
RSVR
| Other | $18.9M | 42% |
| Recorded Music Segment | $12.9M | 28% |
| Performance | $6.2M | 14% |
| Synchronization | $4.6M | 10% |
| Physical | $1.9M | 4% |
| Neighboring Rights | $1.1M | 3% |
RXRX
暂无分部数据
